Molecular Templates (MTEM) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary Engineered Toxin Body (ETB) platform. MTEMs first immunotoxin, MT-3724, is in clinical development for non-Hodgkins lymphoma. Pipeline products for additional oncology targets are being advanced toward clinical development. For more information, please visit MTEMs website at www.mtem.com.
Get notified when new Molecular Templates jobs are posted